申请人:The Trustees of Columbia University in the City of
New York
公开号:EP3323813A1
公开(公告)日:2018-05-23
The invention provides compounds and compositions comprising compounds that modulate histone acyl transferase (HAT). The invention further provides methods for treating neurodegenerative disorders, conditions associated with accumulated amyloid-beta peptide deposits, Tau protein levels, and/or accumulations of alpha-synuclein as well as cancer by administering a compound that modulates HAT to a subject.
本发明提供了包含调节组蛋白酰基转移酶(HAT)的化合物和组合物。本发明进一步提供了通过向受试者施用调节组蛋白酰基转移酶的化合物来治疗神经退行性疾病、与淀粉样β肽沉积、Tau蛋白水平和/或α-突触核蛋白累积有关的疾病以及癌症的方法。